Dawn M Spence, OTR in Delafield, WI - Occupational Therapist

Dawn M Spence, OTR is a Occupational Therapist based in Delafield, Wisconsin. Dawn M Spence is licensed to practice in Wisconsin (license number 2464-64) and her current practice location is N8w33828 Forest Ridge Rd, Delafield, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (262) 646-8254.

NPI number for Dawn M Spence is 1407297526 and her current mailing address is N8w33828 Forest Ridge Rd, Delafield, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1407297526.

Contact Information

	Dawn M Spence, OTR
	N8w33828 Forest Ridge Rd, Delafield, WI 53018-2412
	(262) 646-8254
	Not Available

Healthcare Provider's Profile

Full Name	Dawn M Spence
Gender	Female
Speciality	Occupational Therapist
Location	N8w33828 Forest Ridge Rd, Delafield, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1407297526
Provider Enumeration Date: 07/17/2013
Last Update Date: 07/17/2013

Medical Identifiers

Medical identifiers for Dawn M Spence such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1407297526	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	2464-64 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dawn M Spence is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dawn M Spence, OTR N8w33828 Forest Ridge Rd, Delafield, WI 53018-2412 Ph: (262) 646-8254	Dawn M Spence, OTR N8w33828 Forest Ridge Rd, Delafield, WI 53018-2412 Ph: (262) 646-8254

News Archive

Maintenance TKI therapy 'feasible' for high-risk CML patients after allogeneic HSCT

Patients with high-risk chronic myeloid leukaemia who undergo allogeneic haematopoietic stem cell transplantation may benefit from continuing with tyrosine kinase inhibitor therapy, US clinicians believe.

Majority of 9/11 World Trade Center attack survivors report increased incidence of GERS

Increased incidence of gastroesophageal reflux symptoms (GERS) reported by a large population of 9/11 World Trade Center attack survivors, most of whom had not reported any GERD-related symptoms prior to 9/11, worsened the health-related quality life for many rescue and recovery workers, lower-Manhattan residents and local workers who were exposed to the dust cloud and other contaminants in the aftermath of 9/11, according to a study published online today online today in The American Journal of Gastroenterology.

OphthaliX completes patient enrollment in CF101 Phase II trial for treatment of glaucoma

OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today that it has completed patient enrollment for its Phase II trial of CF101 in the treatment of glaucoma.

Study: More intervention hours are not necessarily better for toddlers with autism

A multisite study led by UC Davis Health found that two prominent early intervention models for autism had a similar impact.

July issue of Neurosurgery provides update on Human Connectome Project

A research effort called the Human Connectome Project is seeking to explore, define, and map the functional connections of the human brain. An update on progress in and upcoming plans for the Human Connectome Project appears in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

Dawn M Spence, OTR - Occupational Therapist in Delafield, WI